iGLS

iGLS is a private Spanish reproductive genetics and immunology diagnostics company focused on assisted reproduction and fertility care. The company provides molecular and genetic testing services to IVF centers, hospitals, healthcare institutions, and in some cases patients, with offerings spanning preconception, preimplantation, prenatal, endometrial, microbiological, and male fertility assessment. Its branded tests include ER Map for endometrial receptivity, MicroBioMap for endometrial microbiota and chronic endometritis assessment, SpermXpression for male infertility analysis based on PRM1/PRM2 expression, and WOMAN MTR for miscarriage and thrombophilia-related reproductive risk. iGLS positions itself as an R&D-driven laboratory and operates accredited clinical services under ISO 15189. Overall, the company is a commercial-stage specialty diagnostics provider rather than a therapeutic drug developer.